20 (R) -Ginsenoside Rh2

O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1O[C@H]2CC[C@]3(C)[C@@]4([H])C[C@@H](O)[C@@H]5[C@@H]([C@](C)(O)CC/C=C(C)\C)CC[C@](C)5[C@@](C)4CC[C@@]3([H])C2(C)C

[1]Choi WY, et al. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20 (R) -ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65 (2) :310-6.|[2]Kang S, et al. Antiviral activity of 20 (R) -ginsenoside Rh2 against murine gammaherpesvirus. J Ginseng Res. 2017 Oct;41 (4) :496-502.|[3]Liu X, et al. Comparative study on the antitumour activity of 20 (R) -ginsenoside Rh2 and 20 (S) -ginsenoside Rh2 from Panax ginseng against non-small cell lung cancer in vitro[J]. Pharmacognosy Magazine, 2022, 18 (80) .|[4]Kim AR, et al. Screening ginseng saponins in progenitor cells identifies 20 (R) -ginsenoside Rh2 as an enhancer of skeletal and cardiac muscle regeneration. Sci Rep. 2020 Mar 18;10 (1) :4967.|[5]Lv Q, et al. Antitumoral Activity of (20R) - and (20S) -Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice. Planta Med. 2016 May;82 (8) :705-11.|[6]Liu J, et al. 20 (R) -ginsenoside Rh2, not 20 (S), is a selective osteoclastgenesis inhibitor without any cytotoxicity. Bioorg Med Chem Lett. 2009 Jun 15;19 (12) :3320-3.